ScholarIQanswers from OpenAlex

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

PaperCitations, authors & open-access status

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis have?

ScholarIQcitation count

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis has 1,088 citations in the OpenAlex counts ScholarIQ stores.

When was Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis published?

ScholarIQyear

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis has 1998 year in the ScholarIQ index.

What is the open-access status of Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis?

ScholarIQoa status

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis has closed oa status in the ScholarIQ index.

What is the DOI of Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis?

ScholarIQdoi

The DOI for Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis is on the source record.

What is the PMID of Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis?

ScholarIQpmid

The PMID for Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis is on the source record.

What is the OpenAlex record for Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis?

ScholarIQopenalex

The OpenAlex for Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial